Terms: = Colorectal cancer AND KAT6B, DKFZp313G1618, 23522, MYST4, ENSG00000156650, Q8WYB5, querkopf, qkf, MOZ2, MORF, KIAA0383, FLJ90335
5 results:
1. Circ-MALAT1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/kat6b axis.
Yang FS; Gong SX; Qiu DD
Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875
[TBL] [Abstract] [Full Text] [Related]
2. A preclinical 188Re tumor therapeutic investigation using morf/cmorf pretargeting and an antiTAG-72 antibody CC49.
Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors.
Pezo RC; Gandhi SJ; Shirley LA; Pestell RG; Augenlicht LH; Singer RH
Cancer Res; 2008 Jul; 68(13):4977-82. PubMed ID: 18593893
[TBL] [Abstract] [Full Text] [Related]
4. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
[TBL] [Abstract] [Full Text] [Related]
5. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
[TBL] [Abstract] [Full Text] [Related]
